Dexin Kong
发表
T. Sakai,
Y. Sowa,
S. Aoki,
2006,
Biochemical and biophysical research communications.
S. Aoki,
Dexin Kong,
Motomasa Kobayashi,
2004,
Anti-cancer drugs.
Dexin Kong,
Qianxiang Zhou,
Yali Chen,
2016,
International journal of biological sciences.
Dexin Kong,
Wennan Zhao,
Yuling Qiu,
2016,
Acta pharmaceutica Sinica. B.
Dexin Kong,
Yu-xu Zhong,
Ran Wang,
2019,
Front. Oncol..
Sangeeta Khare,
Xin Qi,
Ying Wang,
2016
.
Dexin Kong,
Changjiang Huang,
Xiulin Yi,
2016,
Oncotarget.
Dexin Kong,
Ran Wang,
Zhe Zhang,
2017,
Amino Acids.
Y. Li,
Dexin Kong,
Changxiao Liu,
2018,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
Dexin Kong,
Ran Wang,
Meihua Jin,
2014,
Inflammation.
Dexin Kong,
B. Jin,
K. Lee,
2013,
Toxicon : official journal of the International Society on Toxinology.
Dexin Kong,
T. Yamori,
2009,
Current medicinal chemistry.
Zhe Zhang,
Dexin Kong,
Ran Wang,
2018,
Chemical biology & drug design.
Dexin Kong,
H. Duan,
Meina Jin,
2015,
Chemistry of Natural Compounds.
Zhe Zhang,
Guanwei Fan,
Dexin Kong,
2018,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
Shan Zhu,
Dexin Kong,
Yu-xu Zhong,
2018,
Front. Pharmacol..
Dexin Kong,
Wei Huang,
Yuzhu Chen,
2021,
International journal of cancer.
Dexin Kong,
Qianxiang Zhou,
Wennan Zhao,
2013,
International journal of molecular sciences.
Dexin Kong,
T. Yamori,
M. Okamura,
2009,
European journal of cancer.
S. Aoki,
Dexin Kong,
Motomasa Kobayashi,
2004,
Anticancer research.
S. Dan,
Dexin Kong,
Qianxiang Zhou,
2014,
Marine drugs.
Zhe-Sheng Chen,
M. Elkabets,
Dexin Kong,
2021,
Journal of Experimental & Clinical Cancer Research.
Nepetin inhibits IL-1β induced inflammation via NF-κB and MAPKs signaling pathways in ARPE-19 cells.
Dexin Kong,
Xi Chen,
Meihua Jin,
2018,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Dexin Kong,
Xuemin Zheng,
Min Gong,
2015,
Scientific Reports.
Chunze Zhang,
Zhe-Sheng Chen,
Dexin Kong,
2020,
Gastroenterology report.
A. Tomida,
S. Dan,
Dexin Kong,
2008,
Biochemical and biophysical research communications.
Zhe Zhang,
Dexin Kong,
Qianxiang Zhou,
2017,
Oncotarget.
Zhe Zhang,
Guanwei Fan,
Dexin Kong,
2017,
Oncotarget.
Dexin Kong,
Xi Chen,
Ran Wang,
2017,
Inflammation.
Dexin Kong,
Ran Wang,
Shanwen Zhu,
2021,
Life sciences.
Wei Wang,
Dexin Kong,
Meihua Jin,
2022,
Frontiers in Pharmacology.
Dexin Kong,
Yanchao Shi,
Xiaofeng Ma,
2018,
Cellular immunology.
R. Liu,
Dexin Kong,
Hongyan Liu,
2021,
Chemical Engineering Journal.
Dexin Kong,
Guiyou Liu,
J. Hao,
2016,
Journal of Neuroinflammation.
Dexin Kong,
Qianxiang Zhou,
Yali Chen,
2017
.
Dexin Kong,
Ran Wang,
Meihua Jin,
2017,
Inflammation.
Dexin Kong,
Shuyu Luo,
Wenqing Jia,
2022,
Journal of biomolecular structure & dynamics.
S. Dan,
Dexin Kong,
Qianxiang Zhou,
2014,
Inflammation.
Effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor, on DNA-dependent protein kinase.
Dexin Kong,
T. Yamori,
S. Yaguchi,
2009,
Biological & pharmaceutical bulletin.
Dexin Kong,
Qiang Ma,
Shaolu Zhang,
2021
.
Haiyang Yu,
Dexin Kong,
Yuling Qiu,
2022,
Biomolecules & therapeutics.
Ning Zhang,
Dexin Kong,
Sheng-An Tang,
2012,
Journal of natural products.
Dexin Kong,
Ran Wang,
Shanwen Zhu,
2022,
BioMed research international.
Dexin Kong,
Ran Wang,
Meihua Jin,
2018,
International journal of molecular sciences.
Dexin Kong,
Ran Wang,
Meihua Jin,
2018,
Front. Pharmacol..
Dexin Kong,
Xi Chen,
Meihua Jin,
2017,
Immunopharmacology and immunotoxicology.
Dexin Kong,
Li Yanqun,
Rongshao Huang,
2015
.
Dexin Kong,
Motomasa Kobayashi,
Wennan Zhao,
2011,
International journal of molecular sciences.
T. Sakai,
Y. Sowa,
S. Aoki,
2008,
Marine drugs.
Dexin Kong,
Qiang Ma,
Shaolu Zhang,
2020,
Frontiers in Pharmacology.
Ran Wang,
Dexin Kong,
Xi Chen,
2016,
Scientific Reports.
Dexin Kong,
Meihua Jin,
Meina Jin,
2014,
Chemistry of Natural Compounds.
Shan Zhu,
Dexin Kong,
Ran Wang,
2018,
Life sciences.
P. Tu,
Hong Liang,
Dexin Kong,
2018,
Journal of natural products.
Dexin Kong,
Meihua Jin,
T. Yamori,
2011,
Molecules.
Dexin Kong,
Huan Li,
Huanchun Chen,
2016,
Scientific Reports.
Dexin Kong,
Meihua Jin,
Wei Xiaopeng,
2017
.
Dexin Kong,
M. Liao,
X. Hu,
2022,
Frontiers in Immunology.
Ke Li,
Dexin Kong,
Zhe Zhang,
2021,
Bioscience reports.
S. Dan,
Dexin Kong,
Xi Chen,
2015,
Life sciences.
Dexin Kong,
Wennan Zhao,
Wei-ren Xu,
2022,
Molecules.
Shan Zhu,
Dexin Kong,
Ran Wang,
2018,
Frontiers in Pharmacology.
Shan Zhu,
Dexin Kong,
Ran Wang,
2019,
Journal of Cancer Research and Clinical Oncology.
M. Elkabets,
Dexin Kong,
Ran Wang,
2021,
Cell Death & Disease.
Guanwei Fan,
Dexin Kong,
Xi Chen,
2016,
Oncotarget.
S. Dan,
Dexin Kong,
T. Yamori,
2010,
European journal of cancer.
Dexin Kong,
T. Yamori,
2007,
Cancer science.
M. Elkabets,
Dexin Kong,
F. Claret,
2022,
Advanced science.
P. Tu,
Hong Liang,
Dexin Kong,
2019,
Molecules.
Dexin Kong,
Ran Wang,
Meihua Jin,
2021,
Frontiers in Oncology.
Hu Li,
Dexin Kong,
Kitai Kim,
2017,
Stem cell reports.
Dexin Kong,
T. Yamori,
2008,
Cancer science.
S. Dan,
Dexin Kong,
T. Yamori,
2010
.
S. Dan,
Dexin Kong,
T. Yamori,
2014,
Investigational New Drugs.
S. Dan,
Dexin Kong,
T. Yamori,
2014
.
Zhe-Sheng Chen,
Dong-Hua Yang,
Dexin Kong,
2019,
Front. Oncol..
Zhe-Sheng Chen,
Dong-Hua Yang,
Dexin Kong,
2018,
Front. Pharmacol..
Shicui Zhang,
Dexin Kong,
Zhenhui Liu,
2006,
Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
S. Ambudkar,
Zhe-Sheng Chen,
Dexin Kong,
2019,
Cancer letters.
Zhe-Sheng Chen,
Dong-Hua Yang,
Dexin Kong,
2018,
Biochemical pharmacology.
Dexin Kong,
Motomasa Kobayashi,
T. Yamori,
2011,
Marine drugs.
Dexin Kong,
Guiyou Liu,
J. Hao,
2016,
Journal of Neuroinflammation.
S. Aoki,
Dexin Kong,
Motomasa Kobayashi,
2004,
Chemical & pharmaceutical bulletin.
J. Grandis,
A. Porgador,
B. Rotblat,
2021,
Cancers.
Dexin Kong,
Ran Wang,
Meihua Jin,
2019,
International immunopharmacology.
Shujun Zhang,
Dexin Kong,
Liguo Yang,
2013,
International journal of molecular sciences.
Y. Li,
Dexin Kong,
Changxiao Liu,
2017,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
Dexin Kong,
Qianxiang Zhou,
Yali Chen,
2016,
Oncology reports.
Dexin Kong,
Qianxiang Zhou,
Yali Chen,
2016
.
Dexin Kong,
Ran Wang,
Meihua Jin,
2021,
Cell death & disease.
Dexin Kong,
Ran Wang,
Meihua Jin,
2014,
Inflammation.
S. Dan,
Dexin Kong,
Qianxiang Zhou,
2014,
Inflammation.
Xiukun Lin,
Dexin Kong,
Xiaoliang Chen,
2016,
Marine drugs.
Hui Liu,
Tingjun Hou,
Jun Shang,
2017,
Journal of Cheminformatics.
Yan-tao Han,
Chunbo Wang,
Dexin Kong,
2016,
Journal of cardiovascular pharmacology.
Zhe Zhang,
Dexin Kong,
Ran Wang,
2018,
Pathology, research and practice.
Dexin Kong,
T. Yamori,
2012,
Bioorganic & medicinal chemistry.
Dexin Kong,
Meihua Jin,
Eunkyung Lee,
2014,
Planta Medica.
A. Shikov,
Dexin Kong,
Yuanhu Pan,
2021,
Frontiers in Pharmacology.
Dexin Kong,
Meihua Jin,
Yao Liu,
2023,
Frontiers in Pharmacology.
Dexin Kong,
Ran Wang,
Meihua Jin,
2021,
Frontiers in Cell and Developmental Biology.
Dexin Kong,
Ran Wang,
Meihua Jin,
2018,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Sara W. Bird,
Erinna F. Lee,
Michael D. Kim,
2016
.
Dexin Kong,
T. Yamori,
K. Yamazaki,
2010,
Biological & pharmaceutical bulletin.
Lee,
Duchen,
Izzo,
2016
.
Zhe Zhang,
Guanwei Fan,
Dexin Kong,
2019,
Current cancer drug targets.
Dexin Kong,
2012
.
Dexin Kong,
2012
.
Yong Xu,
Dexin Kong,
Xiaohong Yang,
2014,
Bioorganic & medicinal chemistry letters.
Dexin Kong,
H. Duan,
Meina Jin,
2015,
Chemistry of Natural Compounds.
Dexin Kong,
Kaifeng Wang,
Yaohua Fan,
2016,
Biochemical and biophysical research communications.
Zhe-Sheng Chen,
Dexin Kong,
Xiaoping Lin,
2022,
Frontiers in Pharmacology.
Dexin Kong,
Zehui Xu,
Yunying Lv,
2023,
Basic & clinical pharmacology & toxicology.
Dexin Kong,
Meihua Jin,
J. Liu,
2014,
Chemistry of Natural Compounds.
Dexin Kong,
Ran Wang,
Xin Peng,
2021,
Recent patents on anti-cancer drug discovery.
Dexin Kong,
Ran Wang,
Meihua Jin,
2018,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.